- Investor Relations
- 2013 at a Glance
- Shaping the lab of the future
- Letter to the Shareholders
- Interview with CEO David Martyr
- Markets and Market Position
- Life Sciences Business
- Partnering Business
- Corporate Governance
- Financial Report 2013
- Chief Financial Officer’s Report
- Five-year consolidated data
- Consolidated financial statements
- Notes to the consolidated financial statements
- 1 Reporting entity
- 2 Summary of significant accounting policies
- 3 Scope of consolidation
- 4 Segment information
- 5 Operating expenses by nature
- 6 Research and development
- 7 Other operating income
- 8 Financial result
- 9 Earnings per share
- 10 Employee benefits
- 11 Income taxes
- 12 Cash and cash equivalents
- 13 Current loans and derivatives
- 14 Trade accounts receivable
- 15 Inventories
- 16 Non-current financial assets
- 17 Property, plant and equipment
- 18 Intangible assets
- 19 Bank liabilities and derivatives
- 20 Deferred revenue
- 21 Provisions
- 22 Shareholders’ equity
- 23 Foreign exchange rates
- 24 Financial risk management (IFRS 7)
- 25 Fair value measurement and disclosures
- 26 Rental and lease commitments
- 27 Contingent liabilities and encumbrance of assets
- 28 Related parties
- 29 Subsequent events
- 30 Group risk management (disclosure according to Swiss law)
- Balance sheet of Tecan Group Ltd. at December 31
- Income statement of Tecan Group Ltd.
- Notes to the financial statements of Tecan Group Ltd.
- 1 Reporting basis
- 2 Investments in subsidiaries
- 3 Treasury shares
- 4 Provision for general business risks
- 5 Shareholders’ equity
- 6 Guarantees in favor of third parties
- 7 Pledged assets
- 8 Fire insurance value of property, plant and equipment
- 9 Disclosures concerning the conduction of a risk assessment
- 10 Compensation and loans granted to members of the Board of Directors and Management Board
- 11 Share and option ownership of the Board of Directors and Management Board
- Appropriation of available earnings
- The Tecan Share
- Tecan locations
Dako Omnis gives patients peace of mind within a dayThe requirements of automated analytical procedures vary according to the type of disease and the method of diagnosis. Tecan is strategically investing in the development of fully automated solutions for a variety of applications. The company does not always work alone – among its ambitious, highly innovative projects to combat cancer is the development cooperation between Dako and Tecan, which was successfully completed in 2013. Dako Omnis, a new platform for automated advanced staining for tissue-based cancer diagnostics, was launched onto the market in the year under review.
Dako Omnis – a new standard for automated advanced stainingDako Omnis offers full automation and fulfils the requirements of large diagnostic laboratories, hospitals and universities. It offers a high throughput, processes the samples within a few hours and makes it possible to thoroughly analyze individual patient cases within a day.
Dako Omnis offers continuous loading with individual samples or batch loading, as well as the option of leaving the system to run overnight. It therefore sets new standards for what customers can expect from an automated platform with regard to flexibility, capacity, efficiency and traceability of samples. The platform offers state-of-the-art software that is intuitive to operate and allows an improved level of monitoring in the laboratory. Key processes such as slide processing and instrument maintenance can now be traced back to individual employees, which significantly improves quality control.
Main Features of Dako Omnis
No standby time while new reagents and slides are loaded
Minimal hands-on time
Unequaled throughput per working day
Easy to operate thanks to intuitive software
Full IHC and ISH patient case management within a day
Improved quality controls and consistent quality ensured
|January 2010:||Feasibility study|
|October 2010:||Hardware concept|
|May 2011:||Definitive development agreement signed|
|June 2011:||Testing of prototype I|
|April 2012:||Testing of prototype II|
|January 2013:||Validation of the pilot series instruments|
|July 2013:||CE IVD registration|
|September 2013:||Market launch in Europe and US|
In countries with a very dense network of quality controls in particular, people have a great deal of faith in the safety of foodstuffs and pharmaceutical products. This expectation drives all those involved in the production chain to perform each step in the manufacturing process with the greatest care. There is also the associated monitoring of various samples and their continuous documentation. Device manufacturers respond to the great need for reliable, fast sample testing with ever more efficient and complex, yet easy to operate semi- and fully automated systems.
Efficient device development with Tecan OEM componentsTecan supplies OEM components to device manufacturers from its existing portfolio. OEM partner projects allow automation solutions to be developed far quicker and at a much lower cost than when device manufacturers have to rely entirely on their own R&D efforts.
Using proven OEM components such as precision pumps and robotic modules, Tecan facilitates integration into various external environments. A good example of this is Cavro® Omni, a modular, highly expandable robotics module. LCTech, a German manufacturer of products and methods for the preparation and analysis of foodstuffs, animal feeds and environmental samples, has integrated Cavro Omni as the basis of a new sample preparation system.
Efficient automation of routine tasksLCTech customers were asking for an automation solution for everyday routine laboratory tasks. The device needed to be able to link together work steps that had until that point been performed individually and manually. The new robotic system FREESTYLE now enables classic laboratory tasks to be processed automatically. For example, complex samples can be prepared for quality control testing and contamination screening. The basis platform can be combined seamlessly with different processing devices and thus allows different sample preparation technologies to be used for the subsequent analysis - depending on the customer’s preference for a specific technology or regulations.
The new, highly versatile system allows numerous sample preparation work steps in the areas of food and feed testing and environmental analysis to be automated, thus making a contribution to maintaining quality of life.
In the past, the limited nature of 2D cell cultures repeatedly led to promising research projects failing to produce the anticipated results and active pharmaceutical substances ultimately having to be eliminated following expensive test procedures. There is therefore an urgent need for more conclusive, alternative methods for the early phases of testing.
In light of this situation, Tecan has positioned itself in a leading role in this market of the future. To this end, Tecan has entered into cooperation agreements with leading technology companies in the area of cell biology, including InSphero, TAP Biosystems and Reinnervate. The objective is to institute automated test procedures with simplified work steps in the laboratory as quickly as possible.